• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瘙痒活动评分 (PAS):一种监测慢性瘙痒的新工具的有效性和可靠性。

Prurigo Activity Score (PAS): validity and reliability of a new instrument to monitor chronic prurigo.

机构信息

Department of Dermatology, Center for Chronic Pruritus, University Hospital Münster, Münster, Germany.

Comprehensive Wound Center, Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.

出版信息

J Eur Acad Dermatol Venereol. 2018 Oct;32(10):1754-1760. doi: 10.1111/jdv.15040. Epub 2018 Jun 7.

DOI:10.1111/jdv.15040
PMID:29729201
Abstract

BACKGROUND

Currently available tools to monitor patients with chronic prurigo over time focus on pruritus and quality of life parameters, while no instrument objectively assessing the pruriginous lesions is yet available.

OBJECTIVE

The objective of this study was to develop a physician-assessed Prurigo Activity Score (PAS), a new tool to monitor the distribution and activity of chronic prurigo lesions and to evaluate its reliability and validity.

METHODS

The 7-item PAS questionnaire as well as validated pruritus intensity scales (VAS, NRS) and a skin-related quality of life score (DLQI) were completed for 264 patients (172 females, age 61 years) at least twice over a period of 2 years. In addition, a 60-min test-retest reliability test was performed by four experts for a random sample of 12 patients.

RESULTS

The PAS showed good test-retest reliability (Cohens κ > 0.61; Cronbach-alpha > 0.76), ordinal or metric items showed high inter-rater reliability (Kendalls > 0.61) and items recording the number of lesions correlated significantly to each other (P < 0.001). The highest correlation to external constructs was achieved with DLQI. The feasibility test conducted by four raters indicated the suitability of PAS for tracking chronic prurigo in the clinical setting.

DISCUSSION

The PAS is a useful tool to objectively monitor pruriginous lesions in chronic prurigo patients over time. The sensitivity of change in the PAS score should be analysed in future studies.

摘要

背景

目前用于监测慢性瘙痒症患者的工具主要集中在瘙痒和生活质量参数上,而尚未有仪器可客观评估瘙痒性病变。

目的

本研究旨在开发一种医生评估的瘙痒症活动评分(PAS),这是一种新的监测慢性瘙痒症病变分布和活动的工具,并评估其可靠性和有效性。

方法

在至少 2 年内,264 名患者(172 名女性,年龄 61 岁)至少两次完成了 7 项 PAS 问卷以及经过验证的瘙痒强度量表(VAS、NRS)和皮肤相关生活质量评分(DLQI)。此外,还对 12 名随机患者进行了 60 分钟的专家测试-重测可靠性测试。

结果

PAS 具有良好的测试-重测可靠性(Cohens κ > 0.61;Cronbach-α > 0.76),有序或度量项目具有较高的评分者间可靠性(Kendalls > 0.61),记录病变数量的项目彼此之间存在显著相关性(P < 0.001)。与外部结构的相关性最高的是 DLQI。四名评分者进行的可行性测试表明,PAS 适合在临床环境中跟踪慢性瘙痒症。

讨论

PAS 是一种有用的工具,可用于客观监测慢性瘙痒症患者的瘙痒性病变随时间的变化。未来的研究应分析 PAS 评分变化的敏感性。

相似文献

1
Prurigo Activity Score (PAS): validity and reliability of a new instrument to monitor chronic prurigo.瘙痒活动评分 (PAS):一种监测慢性瘙痒的新工具的有效性和可靠性。
J Eur Acad Dermatol Venereol. 2018 Oct;32(10):1754-1760. doi: 10.1111/jdv.15040. Epub 2018 Jun 7.
2
Validation of Psychometric Properties of the Itch Numeric Rating Scale for Pruritus Associated With Prurigo Nodularis: A Secondary Analysis of a Randomized Clinical Trial.验证瘙痒数字评定量表在结节性痒疹相关瘙痒中的心理测量特性:一项随机临床试验的二次分析。
JAMA Dermatol. 2020 Dec 1;156(12):1354-1358. doi: 10.1001/jamadermatol.2020.3071.
3
Validation of a scoring algorithm for the clinician-reported outcome tool 'prurigo activity and severity (PAS)' based on clinical studies of dupilumab in adults with prurigo Nodularis.验证一种基于达必妥治疗结节性痒疹的临床研究的临床医生报告结局工具“瘙痒活动和严重程度(PAS)”评分算法。
J Eur Acad Dermatol Venereol. 2024 Oct;38(10):1954-1964. doi: 10.1111/jdv.19961. Epub 2024 Apr 2.
4
Investigator's Global Assessment of Chronic Prurigo: A New Instrument for Use in Clinical Trials.研究者对慢性痒疹的整体评估:一种用于临床试验的新工具。
Acta Derm Venereol. 2021 Feb 17;101(2):adv00401. doi: 10.2340/00015555-3701.
5
The burden in chronic prurigo: patients with chronic prurigo suffer more than patients with chronic pruritus on non-lesional skin: A comparative, retrospective, explorative statistical analysis of 4,484 patients in a real-world cohort.慢性瘙痒症的负担:与非皮损皮肤慢性瘙痒症患者相比,慢性瘙痒症患者的负担更大:一项真实世界队列中 4484 例患者的比较、回顾性、探索性统计分析。
J Eur Acad Dermatol Venereol. 2021 Mar;35(3):738-743. doi: 10.1111/jdv.16929. Epub 2020 Nov 6.
6
The impact of prurigo nodularis on quality of life: a systematic review and meta-analysis.结节性痒疹对生活质量的影响:系统评价和荟萃分析。
Arch Dermatol Res. 2021 Oct;313(8):669-677. doi: 10.1007/s00403-020-02148-0. Epub 2020 Oct 27.
7
The Sleep Disturbance Numerical Rating Scale: Content Validity, Psychometric Validation, and Meaningful Within-Patient Change in Prurigo Nodularis.睡眠障碍数字评定量表:结节性痒疹的内容效度、心理测量学验证及有意义的患者内变化
Dermatol Ther (Heidelb). 2023 Jul;13(7):1587-1602. doi: 10.1007/s13555-023-00962-8. Epub 2023 Jun 17.
8
Validation of a Comprehensive Set of Pruritus Assessment Instruments: The Chronic Pruritus Tools Questionnaire PRURITOOLS.全面瘙痒评估工具的验证:慢性瘙痒工具问卷 PRURITOOLS。
Acta Derm Venereol. 2019 Jun 1;99(7):657-663. doi: 10.2340/00015555-3158.
9
Dynamic Pruritus Score: Evaluation of the Validity and Reliability of a New Instrument to Assess the Course of Pruritus.动态瘙痒评分:一种评估瘙痒病程的新工具的有效性和可靠性评估
Acta Derm Venereol. 2017 Feb 8;97(2):230-234. doi: 10.2340/00015555-2494.
10
Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: Results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial.炎症性皮肤病患者慢性瘙痒的人文负担:欧洲皮肤病学会和性病学会网络评估瘙痒严重程度和负担(PruNet)横断面研究的结果。
J Am Acad Dermatol. 2018 Sep;79(3):457-463.e5. doi: 10.1016/j.jaad.2018.04.044.

引用本文的文献

1
Content Validity and Psychometric Validation of an Adapted Version of the Subject Sleep Diary in Prurigo Nodularis.结节性痒疹患者睡眠日记改编版的内容效度和心理测量学验证
Dermatol Ther (Heidelb). 2025 Jun;15(6):1405-1426. doi: 10.1007/s13555-025-01406-1. Epub 2025 Apr 23.
2
The Dermatology Life Quality Index (DLQI) used as the benchmark in validation of 101 quality-of-life instruments: A systematic review.皮肤病生活质量指数(DLQI)用作101种生活质量工具验证的基准:一项系统评价。
J Eur Acad Dermatol Venereol. 2025 Mar;39(3):631-679. doi: 10.1111/jdv.20321. Epub 2024 Sep 13.
3
[Chronic prurigo].
[慢性瘙痒症]
Dermatologie (Heidelb). 2023 Nov;74(11):889-898. doi: 10.1007/s00105-023-05222-6. Epub 2023 Sep 18.
4
Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments.慢性瘙痒症,包括结节性瘙痒症:新的见解和治疗方法。
Am J Clin Dermatol. 2024 Jan;25(1):15-33. doi: 10.1007/s40257-023-00818-z. Epub 2023 Sep 17.
5
Validation of the Peak Pruritus Numerical Rating Scale as a Patient-Reported Outcome Measure in Prurigo Nodularis.结节性痒疹患者报告结局测量中峰值瘙痒数字评定量表的验证
Dermatol Ther (Heidelb). 2023 Oct;13(10):2403-2416. doi: 10.1007/s13555-023-00999-9. Epub 2023 Aug 24.
6
Dupilumab for Chronic Prurigo: Case Series on Effectiveness, Safety, and Quality of Life.度普利尤单抗治疗慢性痒疹:有效性、安全性及生活质量的病例系列研究
Dermatology. 2023;239(5):811-817. doi: 10.1159/000531708. Epub 2023 Jun 27.
7
Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study.人源单克隆抑瘤素M受体β抗体维卡瑞单抗治疗中度至重度结节性痒疹的疗效和安全性:一项随机、双盲、安慰剂对照的2a期研究
EClinicalMedicine. 2023 Feb 3;57:101826. doi: 10.1016/j.eclinm.2023.101826. eCollection 2023 Mar.
8
Prurigo Nodularis: A Review of IL-31RA Blockade and Other Potential Treatments.结节性痒疹:IL-31RA阻断及其他潜在治疗方法综述
Dermatol Ther (Heidelb). 2022 Sep;12(9):2039-2048. doi: 10.1007/s13555-022-00782-2. Epub 2022 Aug 20.
9
Abnormal Plasma Levels of Steroids and Their Ratios in Patients With Prurigo Nodularis: A Pilot Study.结节性痒疹患者血浆类固醇水平及其比值异常:一项初步研究。
Front Physiol. 2022 Jun 28;13:835269. doi: 10.3389/fphys.2022.835269. eCollection 2022.
10
Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases.慢性非传染性炎症性皮肤病中未满足的医疗需求。
Front Med (Lausanne). 2022 Jun 9;9:875492. doi: 10.3389/fmed.2022.875492. eCollection 2022.